Major Indexes

My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => COCP [price] => 1.16 [beta] => 0.811362 [volAvg] => 15404200 [mktCap] => 82903808 [lastDiv] => 0 [range] => 0.76-3.46 [changes] => 0.04 [companyName] => Cocrystal Pharma Inc [currency] => USD [cik] => 0001412486 [isin] => US19188J3005 [cusip] => 19188J300 [exchange] => Nasdaq Capital Market [exchangeShortName] => NASDAQ [industry] => Biotechnology [website] => https://www.cocrystalpharma.com/ [description] => Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. The company is headquartered in Bothell, Washington and currently employs 10 full-time employees. The firm focuses on discovering and developing novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The firm focuses on developing and commercializing antiviral drug candidates for the treatment and prophylaxis of hepatitis C, influenza and norovirus. The firm uses computational methods to screen and design product candidates using its cocrystal structural information. The Company’s Hepatitis C Virus (HCV) Non-Nucleoside Polymerase Inhibitor CC-31244 is a pan-genotypic inhibitor of NS5B polymerase for the treatment of hepatitis C infection. The Company’s CC-42344 is a novel PB2 inhibitor for the treatment of influenza infection. The firm is also focused on identifying and developing nucleoside and non-nucleoside polymerase inhibitors for the treatment of Norovirus infections. [ceo] => Dr. Gary Wilcox [sector] => Healthcare [country] => US [fullTimeEmployees] => 13 [phone] => 17864591831 [address] => 19805 N Creek Pkwy [city] => Bothell [state] => WASHINGTON [zip] => 98011 [dcfDiff] => -2.7 [dcf] => 2.22385 [image] => https://financialmodelingprep.com/image-stock/COCP.png [ipoDate] => 2018-03-12 [defaultImage] => [isEtf] => [isActivelyTrading] => 1 ) )
Cocrystal Pharma Inc (COCP)
   1.16   0.04(+3.57%)
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. The company is headquartered in Bothell, Washington and currently employs 10 full-time employees. The firm focuses on discovering and developing novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The firm focuses on developing and commercializing antiviral drug candidates for the treatment and prophylaxis of hepatitis C, influenza and norovirus. The firm uses computational methods to screen and design product candidates using its cocrystal structural information. The Company’s Hepatitis C Virus (HCV) Non-Nucleoside Polymerase Inhibitor CC-31244 is a pan-genotypic inhibitor of NS5B polymerase for the treatment of hepatitis C infection. The Company’s CC-42344 is a novel PB2 inhibitor for the treatment of influenza infection. The firm is also focused on identifying and developing nucleoside and non-nucleoside polymerase inhibitors for the treatment of Norovirus infections.
TitleNamePayCurrency PayGenderYear BornTitle Since
Co-Founder, Chairman of Scientific Advisory Board, Chief Scientist & Director Dr. Roger D. Kornberg N/A USD N/A N/A
Chief Financial Officer & Corporation Sec. Mr. James J. Martin CPA, M.B.A., CPA, MBA 231000 USD male 1967 N/A
Co-Founder & Pres Dr. Sam Lee 241000 USD 1960 N/A
Co-Founder, Chairman & Chief Executive Officer Dr. Gary L. Wilcox 201000 USD 1947 N/A
SymbolDateRatingRating Score Rating Details
COCP 17 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 14 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 13 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 12 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 11 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 10 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 7 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 6 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 5 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 4 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 3 May, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 30 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 29 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 28 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 27 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 26 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 23 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 22 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 21 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 20 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 19 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 16 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 15 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 14 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 13 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 12 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 9 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 8 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 7 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 6 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 5 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 1 April, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 31 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 30 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 29 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 26 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 25 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 24 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 23 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 22 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 19 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 18 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 17 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 16 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 15 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 12 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 11 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 10 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 9 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 8 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 5 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 4 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 3 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 2 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 1 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 26 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 25 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 24 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 23 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 22 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 19 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 18 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 17 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 5 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 4 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 3 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 2 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 1 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 29 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 28 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 27 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 26 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 25 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 22 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 21 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 20 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 19 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 15 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 14 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 13 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 12 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 11 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 8 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 7 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 6 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 5 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 4 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 31 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 30 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 29 December, 2020 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
COCP 28 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 24 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 23 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 22 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 21 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 18 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 17 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 16 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 15 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
COCP 14 December, 2020 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HolderSharesDate ReportedChange
JPMORGAN CHASE & CO 1404 31 March, 2021 1404
CIM, LLC 11000 31 March, 2021 11000
GLOBAL TRUST ASSET MANAGEMENT, LLC 1001 31 March, 2021 1001
Parallel Advisors, LLC 193708 31 March, 2021 193708
North Star Investment Management Corp. 2250 31 March, 2021 2250
Bank of New York Mellon Corp 44522 31 March, 2021 44522
Focused Wealth Management, Inc 250 31 March, 2021 250
RENAISSANCE TECHNOLOGIES LLC 4254880 31 March, 2021 304900
BARCLAYS PLC 16495 31 March, 2021 16495
HighTower Advisors, LLC 36001 31 March, 2021 36001
Qube Research & Technologies Ltd 17266 31 March, 2021 17266
Archer Investment Corp 500 31 March, 2021 500
BANK OF AMERICA CORP /DE/ 107761 31 March, 2021 0
CAPTRUST FINANCIAL ADVISORS 266 31 March, 2021 -4000
GOLDMAN SACHS GROUP INC 32270 31 December, 2020 -57118
HIGHTOWER ADVISORS, LLC 31100 31 December, 2020 31100
MILLENNIUM MANAGEMENT LLC 21499 31 December, 2020 21499
COMMONWEALTH EQUITY SERVICES, LLC 16500 31 December, 2020 16500
JANE STREET GROUP, LLC 11574 31 December, 2020 -29488
CLEAN YIELD GROUP 5000 31 December, 2020 5000
ADVISOR GROUP HOLDINGS, INC. 2533 31 December, 2020 2000
NORTH STAR INVESTMENT MANAGEMENT CORP. 2250 31 December, 2020 0
SAMALIN INVESTMENT COUNSEL, LLC 1000 31 December, 2020 0
WELLS FARGO & COMPANY/MN 747 31 December, 2020 470
JOSEPH P. LUCIA & ASSOCIATES, LLC 605 31 December, 2020 605
FOCUSED WEALTH MANAGEMENT, INC 400 31 December, 2020 400
HOWE & RUSLING INC 250 31 December, 2020 250
SOWELL FINANCIAL SERVICES LLC 178 31 December, 2020 178
SALEM INVESTMENT COUNSELORS INC 8 31 December, 2020 8
NATIONAL ASSET MANAGEMENT, INC. 12726 31 December, 2020 -1
VANGUARD GROUP INC 1957773 31 December, 2020 701724
BLACKROCK INC. 1106970 31 December, 2020 1106970
POINT72 ASSET MANAGEMENT, L.P. 1000000 31 December, 2020 -1857143
MORGAN STANLEY 713240 31 December, 2020 0
GEODE CAPITAL MANAGEMENT, LLC 331720 31 December, 2020 76324
PARALLEL ADVISORS, LLC 202208 31 December, 2020 73645
DIMENSIONAL FUND ADVISORS LP 190674 31 December, 2020 0
VERITION FUND MANAGEMENT LLC 180000 31 December, 2020 0
QUBE RESEARCH & TECHNOLOGIES LTD 100023 31 December, 2020 -127066
NORTHERN TRUST CORP 80967 31 December, 2020 -3825
BANK OF NEW YORK MELLON CORP 49346 31 December, 2020 49346
BRIGHTON JONES LLC 36000 31 December, 2020 18000
VIRTU FINANCIAL LLC 34394 31 December, 2020 -57290
HolderSharesDate ReportedWeight Percent
DIMENSIONAL FUND ADVISORS LP 190674 31 March, 2021 N/A
Verition Fund Management LLC 180000 16 February, 2021 N/A
Vanguard Total Stock Market Index Fund 583208 31 August, 2020 N/A
Fidelity Series Total Market Index Fund 31028 31 July, 2020 N/A
Vanguard US Equity Index Fund 17995 31 July, 2020 N/A
Fidelity NASDAQ Composite Index Fund 17894 31 July, 2020 N/A
Vanguard Balanced Index Fund 17553 31 July, 2020 N/A
Fidelity Extended Market Index Fund 226784 31 July, 2020 N/A
Vanguard Extended Market Index Fund 489424 31 July, 2020 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
COCP 4 May, 2021 0001397607 7674960 0001412486 Schinazi Raymond F D 4 575000 Common Stock View
COCP 24 November, 2020 0001602074 50000 0001412486 Lee Sam A 5 50000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0001381874 72000 0001412486 Rubin Steven D A 4 72000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0000898860 50000 0001412486 FROST PHILLIP MD ET AL A 4 50000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0001510224 150000 0001412486 Martin James Joseph A 4 150000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0001444532 50000 0001412486 Kornberg Roger D. A 4 50000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0001602074 100000 0001412486 Lee Sam A 4 100000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0001222257 200000 0001412486 WILCOX GARY A 4 200000 Stock Options (Right to Buy) View
COCP 22 June, 2020 0001773088 56000 0001412486 Japour Anthony J A 4 56000 Stock Options (Right to Buy) View
COCP 25 October, 2019 0001397607 9257863 0001412486 Schinazi Raymond F A 4 7906 Common Stock View
COCP 24 October, 2019 0001397607 9249957 0001412486 Schinazi Raymond F A 4 5094 Common Stock View
COCP 23 October, 2019 0001397607 9244863 0001412486 Schinazi Raymond F A 4 3935 Common Stock View
COCP 21 September, 2018 0001510224 150000 0001412486 Martin James Joseph A 4 150000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0001222257 200000 0001412486 WILCOX GARY A 4 200000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0001222646 50000 0001412486 BLOCK DAVID S A 4 50000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0001397607 50000 0001412486 Schinazi Raymond F A 4 50000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0000898860 50000 0001412486 FROST PHILLIP MD ET AL A 4 50000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0001381874 50000 0001412486 Rubin Steven D A 4 50000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0001602074 100000 0001412486 Lee Sam A 4 100000 Stock Options (Right to Buy) View
COCP 21 September, 2018 0001188834 50000 0001412486 HSIAO JANE PH D A 4 50000 Stock Options (Right to Buy) View
COCP 10 May, 2018 0001397607 263158 0001412486 Schinazi Raymond F D 4 263158 8% Convertible Note View
COCP 10 May, 2018 0001397607 995593 0001412486 Schinazi Raymond F A 4 10209 Common Stock View
COCP 10 May, 2018 0001397607 263158 0001412486 Schinazi Raymond F A 4 263158 8% Convertible Note View
COCP 10 May, 2018 0001397607 985384 0001412486 Schinazi Raymond F A 4 263158 Common Stock View
COCP 10 May, 2018 0001397607 61728 0001412486 Schinazi Raymond F D 4 61728 8% Convertible Note View
COCP 3 May, 2018 0000898860 3655265 0001412486 FROST PHILLIP MD ET AL A 4 105263 Common Stock View
COCP 3 May, 2018 0001397607 722226 0001412486 Schinazi Raymond F A 4 420737 Common Stock View
COCP 24 November, 2017 0001397607 1851851 0001412486 Schinazi Raymond F A 4 1851851 8% Convertible Note View
COCP 11 July, 2017 0001397607 277227831 0001412486 Schinazi Raymond F A 4 1706978 Common Stock View
COCP 11 July, 2017 0001397607 0 0001412486 Schinazi Raymond F D 4 1706978 Stock Options (Right to Buy) View
COCP 20 April, 2017 0001397607 9044717 0001412486 Schinazi Raymond F A 4 4166667 Common Stock View
COCP 23 December, 2016 0001602074 13087847 0001412486 Lee Sam D 4 2200000 Common Stock View
COCP 1 September, 2016 0001222257 16948605 0001412486 WILCOX GARY A 4 10000 Common Stock View
COCP 1 September, 2016 0001397607 4878050 0001412486 Schinazi Raymond F A 4 4878050 Common Stock View
COCP 1 September, 2016 0001222646 168696 0001412486 BLOCK DAVID S A 4 10000 Common Stock View
COCP 15 March, 2016 0001188834 3435294 0001412486 HSIAO JANE PH D A 4 1235294 Common Stock View
COCP 15 March, 2016 0001381874 93564 0001412486 Rubin Steven D A 4 39216 Common Stock View
COCP 15 March, 2016 0001222257 16938605 0001412486 WILCOX GARY A 4 49020 Common Stock View
COCP 15 March, 2016 0001222646 158696 0001412486 BLOCK DAVID S A 4 50000 Common Stock View
COCP 15 March, 2016 0001506916 657161 0001412486 Meckler Jeffrey A A 4 294118 Common Stock View
COCP 15 March, 2016 0000898860 106500147 0001412486 FROST PHILLIP MD ET AL A 4 2941177 Common Stock View
COCP 15 March, 2016 0001381874 733484 0001412486 Rubin Steven D A 4/A 39216 Common Stock View
COCP 15 March, 2016 0001397607 275520853 0001412486 Schinazi Raymond F A 4 2941176 Common Stock View
COCP 23 December, 2015 0001506916 363043 0001412486 Meckler Jeffrey A A 4 100000 Common Stock View
COCP 24 November, 2015 0001658378 100000 0001412486 Dale Curtis A 4 100000 Stock options (Right to Buy) View
COCP 1 October, 2015 0001393646 2400000 0001412486 Mayers Douglas L A 4 2400000 Stock Options (Right to buy) View
COCP 1 October, 2015 0001506916 16000000 0001412486 Meckler Jeffrey A A 4 16000000 Stock Option (Right to Buy) View
COCP 21 July, 2015 0001648585 1200000 0001412486 Linscott Walt Addison A 4 1200000 Stock options (right to buy) View
COCP 21 April, 2015 0001397607 272579677 0001412486 Schinazi Raymond F A 4 3464855 Common Stock View
COCP 13 April, 2015 0001601965 200000 0001412486 McGuire Gerald A A 4 200000 Stock options (Right to buy) View
COCP 13 April, 2015 0001222646 350000 0001412486 BLOCK DAVID S A 4 350000 Stock options (Right to buy) View
COCP 13 April, 2015 0001381874 350000 0001412486 Rubin Steven D A 4 350000 Stock options (Right to buy) View
COCP 13 April, 2015 0000898860 350000 0001412486 FROST PHILLIP MD ET AL A 4 350000 Stock options (Right to buy) View
COCP 13 April, 2015 0001188834 350000 0001412486 HSIAO JANE PH D A 4 350000 Stock options (Right to buy) View
COCP 13 April, 2015 0001397607 350000 0001412486 Schinazi Raymond F A 4 350000 Stock options (Right to buy) View
COCP 25 March, 2015 0001506916 263043 0001412486 Meckler Jeffrey A A 4 163043 Common Stock View
COCP 25 March, 2015 0001188834 2200000 0001412486 HSIAO JANE PH D A 4 2200000 Common Stock View
COCP 25 March, 2015 0001222257 16889585 0001412486 WILCOX GARY A 4 54348 Common Stock View
COCP 25 March, 2015 0001381874 694268 0001412486 Rubin Steven D A 4 54348 Common Stock View
COCP 25 March, 2015 0001222646 108696 0001412486 BLOCK DAVID S A 4 108696 Common Stock View
COCP 25 March, 2015 0000898860 103558969 0001412486 FROST PHILLIP MD ET AL A 4 3464855 Common Stock View
COCP 23 March, 2015 0001506916 1750000 0001412486 Meckler Jeffrey A A 4 1750000 Stock Option (Right to Buy) View
COCP 3 March, 2015 0001397607 269114822 0001412486 Schinazi Raymond F A 4 269114822 Common Stock View
COCP 3 March, 2015 0001397607 0 0001412486 Schinazi Raymond F D 4 789747 Series A Convertible Preferred Stock View
COCP 3 March, 2015 0000898860 100094114 0001412486 FROST PHILLIP MD ET AL A 4 87726389 Common Stock View
COCP 3 March, 2015 0000898860 0 0001412486 FROST PHILLIP MD ET AL D 4 427760 Series B Convertible Preferred Stock View
COCP 3 March, 2015 0001602074 15287847 0001412486 Lee Sam A 4 15287847 Common Stock View
COCP 3 March, 2015 0001602074 0 0001412486 Lee Sam D 4 74545 Series B Preferred Stock View
COCP 3 March, 2015 0001222257 16835237 0001412486 WILCOX GARY A 4 16835237 Common Stock View
COCP 3 March, 2015 0001222257 0 0001412486 WILCOX GARY D 4 82090 Series B Preferred Stock View
COCP 3 March, 2015 0001188834 5496654 0001412486 HSIAO JANE PH D A 4 5496654 Common Stock View
COCP 3 March, 2015 0001188834 0 0001412486 HSIAO JANE PH D D 4 53626802 Series B Convertible Preferred Stock View
COCP 3 March, 2015 0001381874 639920 0001412486 Rubin Steven D A 4 109920 Common Stock View
COCP 3 March, 2015 0001381874 0 0001412486 Rubin Steven D D 4 536 Series B Convertible Preferred Stock View
COCP 15 December, 2014 0000898860 12348852 0001412486 FROST PHILLIP MD ET AL A 4 6127 Common Stock View
COCP 15 December, 2014 0000898860 12357725 0001412486 FROST PHILLIP MD ET AL A 4 8873 Common Stock View
COCP 15 December, 2014 0000898860 12367725 0001412486 FROST PHILLIP MD ET AL A 4 10000 Common Stock View
COCP 11 December, 2014 0001506916 25000 0001412486 Meckler Jeffrey A A 4 25000 Common Stock View
COCP 11 December, 2014 0001506916 50000 0001412486 Meckler Jeffrey A A 4 25000 Common Stock View
COCP 11 December, 2014 0001506916 100000 0001412486 Meckler Jeffrey A A 4 50000 Common Stock View
COCP 25 November, 2014 0001397607 798747 0001412486 Schinazi Raymond F A 4 798747 Series A Convertible Preferred Stock View
COCP 25 November, 2014 0001397607 1706978 0001412486 Schinazi Raymond F A 4 1706978 Stock Options (Right to Buy) View
COCP 12 August, 2014 0000898860 12342725 0001412486 FROST PHILLIP MD ET AL A 4 66200 Common Stock View
COCP 11 August, 2014 0000898860 12276525 0001412486 FROST PHILLIP MD ET AL A 4 45000 Common Stock View
SymbolDatePeriodDownload XLSX File
COCP 2021 FY Download XLSX File
COCP 2020 FY Download XLSX File
COCP 2019 FY Download XLSX File
COCP 2018 FY Download XLSX File
COCP 2017 FY Download XLSX File
COCP 2016 FY Download XLSX File
COCP 2015 FY Download XLSX File
COCP 2014 FY Download XLSX File
COCP 2013 FY Download XLSX File
COCP 2021 Q1 Download XLSX File
COCP 2020 Q2 Download XLSX File
COCP 2020 Q4 Download XLSX File
COCP 2020 Q1 Download XLSX File
COCP 2020 Q3 Download XLSX File
COCP 2019 Q3 Download XLSX File
COCP 2019 Q2 Download XLSX File
COCP 2019 Q4 Download XLSX File
COCP 2019 Q1 Download XLSX File
COCP 2018 Q2 Download XLSX File
COCP 2018 Q4 Download XLSX File
COCP 2018 Q3 Download XLSX File
COCP 2018 Q1 Download XLSX File
COCP 2017 Q1 Download XLSX File
COCP 2017 Q3 Download XLSX File
COCP 2017 Q2 Download XLSX File
COCP 2017 Q4 Download XLSX File
COCP 2016 Q2 Download XLSX File
COCP 2016 Q3 Download XLSX File
COCP 2016 Q4 Download XLSX File
COCP 2016 Q1 Download XLSX File
COCP 2015 Q4 Download XLSX File
COCP 2015 Q3 Download XLSX File
COCP 2015 Q1 Download XLSX File
COCP 2015 Q2 Download XLSX File
COCP 2014 Q1 Download XLSX File
COCP 2014 Q4 Download XLSX File
COCP 2014 Q2 Download XLSX File
COCP 2014 Q3 Download XLSX File
COCP 2013 Q3 Download XLSX File
COCP 2013 Q4 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
17 May, 2021 COCP -0.04 -0.04 bmo 0 0
17 March, 2021 COCP -0.02 -0.02 bmo 510000 0
13 November, 2020 COCP -0.05 -0.05 bmo 489000 0
6 August, 2020 COCP -0.07 -0.07 bmo 554000 316571.42857143
13 May, 2020 COCP -0.05 -0.05 bmo 461000 737600
27 March, 2020 COCP -0.05 -0.05 bmo 402000 562800
12 November, 2019 COCP -0.06 -0.06 bmo 492000 656000
9 August, 2019 COCP -0.05 -0.05 bmo 592000 828800
10 May, 2019 COCP -0.07 -0.07 bmo 5078000 5803428.5714286
1 April, 2019 COCP 0.34 0.34 bmo 5078000 1194823.5294118
9 November, 2018 COCP -0.06 -0.06 bmo 0 0
9 August, 2018 COCP bmo 0 0
10 May, 2018 COCP bmo 0 0
21 March, 2018 COCP bmo 0 0

Company Profile

Company Name Cocrystal Pharma Inc
Symbol COCP
Currency USD
Price 1.16
Exchange Name Nasdaq Capital Market (NASDAQ)
Industry Biotechnology
CEO Dr. Gary Wilcox
Sector Healthcare
Country US
Full Time Employees 13
Phone 17864591831
Address 19805 N Creek Pkwy
City Bothell
State WASHINGTON
Zip 98011
>